Socioeconomic and Ethnic Disparities in Periocular Cutaneous Malignancies

REFERENCES

• Simões MCF, Sousa JJS, Pais AACC. Skin cancer and new treatment perspectives: A review. Cancer Lett 2015;357:8–42.
   PubMed Web of Science ®Google Scholar
• Cook BE, Bartley GB. Epidemiologic characteristics and clinical course of patients with malignant eyelid tumors in an incidence cohort in Olmsted County, Minnesota. Ophthalmology 1999;106:746–750.
   PubMed Web of Science ®Google Scholar
• Zeitouni NC, Raghu PR, Mansour TN. Orbital invasion by periocular infiltrating basal cell carcinoma. Dermatol Surg 2012;38:2025–2027.
   Google Scholar
• Malhotra R, Huilgol SC, Huynh NT, et al. The Australian Mohs database, part I: Periocular basal cell carcinoma experience over 7 years. Ophthalmology 2004;111:624–630.
   PubMed Web of Science ®Google Scholar
• Wu A, Sun MT, Huilgol SC, et al. Histological subtypes of periocular basal cell carcinoma. Clin Experiment Ophthalmol 2014;42:603–607.
   PubMed Web of Science ®Google Scholar
• Slutsky JB, Jones EC. Periocular cutaneous malignancies: A review of the literature. Dermatol Surg 2012;38:552–569.
   PubMed Web of Science ®Google Scholar
• Walling HW, Fosko SW, Geraminejad PA, et al. Aggressive basal cell carcinoma: Presentation, pathogenesis, and management. Cancer Metastasis Rev 2004;23:389–402.
   PubMed Web of Science ®Google Scholar
• Leibovitch I, McNab A, Sullivan T, et al. Orbital invasion by periocular basal cell carcinoma. Ophthalmology 2005;112:717–723.
   PubMed Web of Science ®Google Scholar
• Glatt HJ, Olson JJ, Putterman AM. Conventional frozen sections in periocular basal-cell carcinoma: A review of 236 cases. Ophthalmic Surg 1992;23:6–8.
   PubMedGoogle Scholar
• Robins P, Rodríguez-Sains R, Rabinovitz H, et al. Mohs surgery for periocular basal cell carcinomas. J Dermatol Surg Oncol 1985;11:1203–1207.
   Google Scholar
• Narayanan K, Hadid OH, Barnes EA. Mohs micrographic surgery versus surgical excision for periocular basal cell carcinoma. Cochrane Database Syst Rev 2014;12:CD007041.
   PubMed Web of Science ®Google Scholar
• Battie C, Gohara M, Verschoore M, et al. Skin cancer in skin of color: An update on current facts, trends, and misconceptions. J Drugs Dermatol 2013;12:194–198.
   PubMed Web of Science ®Google Scholar
• Steding-Jessen M, Birch-Johansen F, Jensen A, et al. Socioeconomic status and non-melanoma skin cancer: A nationwide cohort study of incidence and survival in Denmark. Cancer Epidemiol 2010;34:689–695.
   PubMed Web of Science ®Google Scholar
• Gloster HM, Neal K. Skin cancer in skin of color. J Am Acad Dermatol 2006;55:741–760;
   PubMed Web of Science ®Google Scholar
• Harris RB, Griffith K, Moon TE. Trends in the incidence of nonmelanoma skin cancers in southeastern Arizona, 1985-1996. J Am Acad Dermatol 2001;45:528–536.
   PubMed Web of Science ®Google Scholar
• Agbai ON, Buster K, Sanchez M, et al. Skin cancer and photoprotection in people of color: A review and recommendations for physicians and the public. J Am Acad Dermatol 2014;70:748–762.
   PubMed Web of Science ®Google Scholar
• Doherty VR, Brewster DH, Jensen S, et al. Trends in skin cancer incidence by socioeconomic position in Scotland, 1978-2004. Br J Cancer 2010;102:1661–1664.
   Google Scholar
• Van Hattem S, Aarts MJ, Louwman WJ, et al. Increase in basal cell carcinoma incidence steepest in individuals with high socioeconomic status: Results of a cancer registry study in The Netherlands. Br J Dermatol 2009;161:840–845.
   PubMed Web of Science ®Google Scholar
• Lim LT, Agarwal PK, Young D, et al. The effect of socio-economic status on severity of periocular basal cell carcinoma at presentation. Ophthal Plast Reconstr Surg 2015;31(6):456–458.
   Google Scholar
• Robinson JK, Altman JS, Rademaker AW. Socioeconomic status and attitudes of 51 patients with giant basal and squamous cell carcinoma and paired controls. Arch Dermatol 1995;131:428–431.
   PubMedGoogle Scholar
• Robinson JK, Altman JS, Rademaker AW. Socioeconomic status and attitudes of 51 patients with giant basal and squamous cell carcinoma and paired controls. Arch Dermatol 1995;131:428–431.
   PubMedGoogle Scholar
• Randle HW, Roenigk RK, Brodland DG. Giant basal cell carcinoma (T3): Who is at risk? Cancer 1993;72:1624–1630.
   PubMed Web of Science ®Google Scholar
• DeConti RC. Chemotherapy of squamous cell carcinoma of the skin. Semin Oncol 2012;39:145–149.
   PubMed Web of Science ®Google Scholar
• Malhotra R, Huilgol SC, Huynh NT, et al. The Australian Mohs database: Periocular squamous cell carcinoma. Ophthalmology 2004;111:617–623.
   PubMed Web of Science ®Google Scholar
• Faustina M, Diba R, Ahmadi MA, et al. Patterns of regional and distant metastasis in patients with eyelid and periocular squamous cell carcinoma. Ophthalmology 2004;111:1930–1932.
   Google Scholar
• Rene C. Oculoplastic aspects of ocular oncology. Eye Lond Engl 2013;27:199–207.
   PubMed Web of Science ®Google Scholar
• Weinberg AS, Ogle CA, Shim EK. Metastatic cutaneous squamous cell carcinoma: An update. Dermatol Surg 2007;33:885–899.
   PubMed Web of Science ®Google Scholar
• Donaldson MJ, Sullivan TJ, Whitehead KJ, et al. Squamous cell carcinoma of the eyelids. Br J Ophthalmol 2002;86:1161–1165.
   Google Scholar
• Rossi R, Puccioni M, Mavilia L, et al. Squamous cell carcinoma of the eyelid treated with photodynamic therapy. J Chemother Florence Italy 2004;16:306–309.
   PubMed Web of Science ®Google Scholar
• Ross AH, Kennedy CTC, Collins C, et al. The use of imiquimod in the treatment of periocular tumours. Orbit Amst Neth 2010;29:83–87.
   PubMedGoogle Scholar
• Hemminki K, Li X. Level of education and the risk of cancer in Sweden. Cancer Epidemiol Biomark 2003;12:796–802.
   PubMed Web of Science ®Google Scholar
• Weinstock MA. Nonmelanoma skin cancer mortality in the United States, 1969 through 1988. Arch Dermatol 1993;129:1286–1290.
   PubMedGoogle Scholar
• Kakagia D, Trypsiannis G, Karanikas M, et al. Patient-related delay in presentation for cutaneous squamous cell carcinoma: A cross-sectional clinical study. Onkologie 2013;36:738–744.
   PubMedGoogle Scholar
• Vaziri M, Buffam FV, Martinka M, et al. Clinicopathologic features and behavior of cutaneous eyelid melanoma. Ophthalmology 2002;109:901–908.
   PubMed Web of Science ®Google Scholar
• Chan FM, O’Donnell BA, Whitehead K, et al. Treatment and outcomes of malignant melanoma of the eyelid: A review of 29 cases in Australia. Ophthalmology 2007;114:187–192.
   PubMed Web of Science ®Google Scholar
• Anderson KW, Baker SR, Lowe L, et al. Treatment of head and neck melanoma, lentigo maligna subtype: A practical surgical technique. Arch Facial Plast Surg 2001;3:202–206.
   PubMedGoogle Scholar
• Esmaeli B, Wang B, Deavers M, et al. Prognostic factors for survival in malignant melanoma of the eyelid skin. Ophthal Plast Reconstr Surg 2000;16:250–257.
   PubMed Web of Science ®Google Scholar
• Ringborg U, Afzelius LE, Lagerlöf B, et al. Cutaneous malignant melanoma of the head and neck: Analysis of treatment results and prognostic factors in 581 patients: A report from the Swedish Melanoma Study Group. Cancer 1993;71:751–758.
   Google Scholar
• Harish V, Bond JS, Scolyer RA, et al. Margins of excision and prognostic factors for cutaneous eyelid melanomas. J Plast Reconstr Aesthetic Surg 2013;66:1066–1073.
   Google Scholar
• Ly L, Kelly JW, O’Keefe R, et al. Efficacy of imiquimod cream, 5%, for lentigo maligna after complete excision: A study of 43 patients. Arch Dermatol 2011;147:1191–1195.
   PubMedGoogle Scholar
• Kirtschig G, van Meurs T, van Doorn R. Twelve-week treatment of lentigo maligna with imiquimod results in a high and sustained clearance rate. Acta Derm Venereol 2015;95:83–85.
   PubMed Web of Science ®Google Scholar
• Tzellos T, Kyrgidis A, Mocellin S, et al. Interventions for melanoma in situ, including lentigo maligna. Cochrane Database Syst Rev 2014;12:CD010308.
   PubMed Web of Science ®Google Scholar
• Ortiz CAR, Goodwin JS, Freeman JL. The effect of socioeconomic factors on incidence, stage at diagnosis and survival of cutaneous melanoma. Med Sci Monit Int Med J Exp Clin Res 2005;11:RA163–172.
   Google Scholar
• Harvey VM, Patel H, Sandhu S, et al. Social determinants of racial and ethnic disparities in cutaneous melanoma outcomes. Cancer Control J Moffitt Cancer Cent 2014;21:343–349.
   PubMed Web of Science ®Google Scholar
• Forman D, Bray F, Brewster D, et al. Cancer Incidence in Five Continents, Vol. X; Lyon: International Agency for Research on Cancer, 2014.
   Google Scholar
• Cormier JN, Xing Y, Ding M, et al. Ethnic differences among patients with cutaneous melanoma. Arch Intern Med 2006;166:1907–1914.
   Google Scholar
• Singh SD, Ajani UA, Johnson CJ, et al. Association of cutaneous melanoma incidence with area-based socioeconomic indicators: United States, 2004-2006. J Am Acad Dermatol 2011;65:S58–68.
   PubMed Web of Science ®Google Scholar
• Pollitt RA, Clarke CA, Swetter SM, et al. The expanding melanoma burden in California Hispanics: Importance of socioeconomic distribution, histologic subtype, and anatomic location. Cancer 2011;117:152–161.
   PubMed Web of Science ®Google Scholar
• Hu S, Parmet Y, Allen G, et al. Disparity in melanoma: A trend analysis of melanoma incidence and stage at diagnosis among whites, Hispanics, and blacks in Florida. Arch Dermatol 2009;145:1369–1374.
   Google Scholar
• Clairwood M, Ricketts J, Grant-Kels J, et al. Melanoma in skin of color in Connecticut: An analysis of melanoma incidence and stage at diagnosis in non-Hispanic blacks, non-Hispanic whites, and Hispanics. Int J Dermatol 2014;53:425–433.
   PubMed Web of Science ®Google Scholar
• Reyes-Ortiz CA, Goodwin JS, Freeman JL, et al. Socioeconomic status and survival in older patients with melanoma. J Am Geriatr Soc 2006;54:1758–1764.
   Google Scholar
• Geller AC, Miller DR, Lew RA, et al. Cutaneous melanoma mortality among the socioeconomically disadvantaged in Massachusetts. Am J Public Health 1996;86:538–544.
   PubMed Web of Science ®Google Scholar
• Mandalà M, Imberti GL, Piazzalunga D, et al. Association of socioeconomic status with Breslow thickness and disease-free and overall survival in Stage I-II primary cutaneous melanoma. Mayo Clin Proc 2011;86:113–119.
   PubMed Web of Science ®Google Scholar
• Cokkinides VE, Geller AC, Jemal A. Trends in melanoma mortality among non-Hispanic whites by educational attainment, 1993-2007. Arch Dermatol 2012;148:587–591.
   PubMedGoogle Scholar
• Singh G, Miller B, Hankey B, et al. Area Socioeconomic Variations in U.S. Cancer Incidence, Mortality, Stage, Treatment, and Survival, 1975–1999; Bethesda, MD: National Cancer Institute, 2003.
   Google Scholar
• Roetzheim RG, Pal N, Tennant C, et al. Effects of health insurance and race on early detection of cancer. J Natl Cancer Inst 1999;91:1409–1415.
   Google Scholar
• Roetzheim RG, Pal N, van Durme DJ, et al. Increasing supplies of dermatologists and family physicians are associated with earlier stage of melanoma detection. J Am Acad Dermatol 2000;43:211–218.
   PubMed Web of Science ®Google Scholar
• Ocaña-Riola R, Sánchez-Cantalejo C, Rosell J, et al. Socio-economic level, farming activities and risk of cancer in small areas of southern Spain. Eur J Epidemiol 2004;19:643–650.
   PubMed Web of Science ®Google Scholar
• Buster KJ, You Z, Fouad M, et al. Skin cancer risk perceptions: A comparison across ethnicity, age, education, gender, and income. J Am Acad Dermatol 2012;66:771–779.
   PubMed Web of Science ®Google Scholar
• Kundu RV, Kamaria M, Ortiz S, et al. Effectiveness of a knowledge-based intervention for melanoma among those with ethnic skin. J Am Acad Dermatol 2010;62:777–784.
   PubMed Web of Science ®Google Scholar
• Cheng CE, Irwin B, Mauriello D, et al. Health disparities among different ethnic and racial middle and high school students in sun exposure beliefs and knowledge. J Adolesc Health 2010;47:106–109.
   PubMed Web of Science ®Google Scholar
• Miller DR, Geller AC, Wyatt SW, et al. Melanoma awareness and self-examination practices: Results of a United States survey. J Am Acad Dermatol 1996;34:962–970.
   PubMed Web of Science ®Google Scholar
• Friedman LC, Bruce S, Weinberg AD, et al. Early detection of skin cancer: Racial/ethnic differences in behaviors and attitudes. J Cancer Educ 1994;9:105–110.
   PubMedGoogle Scholar
• Arnold MR, DeJong W. Skin self-examination practices in a convenience sample of U.S. university students. Prev Med 2005;40:268–273.
   PubMed Web of Science ®Google Scholar
• Imahiyerobo-Ip J, Ip I, Jamal S, et al. Skin cancer awareness in communities of color. J Am Acad Dermatol 2011;64:198–200.
   PubMed Web of Science ®Google Scholar
• Saraiya M, Hall HI, Thompson T, et al. Skin cancer screening among U.S. adults from 1992, 1998, and 2000 National Health Interview Surveys. Prev Med 2004;39:308–314.
   PubMed Web of Science ®Google Scholar
• Janda M, Youl PH, Lowe JB, et al. Attitudes and intentions in relation to skin checks for early signs of skin cancer. Prev Med 2004;39:11–18.
   PubMed Web of Science ®Google Scholar